|SOUTH-EAST EUROPEAN INDUSTRIAL МARKET » South-East European INDUSTRIAL Мarket - issue 4/2016, November
Hemofarm will acquire Ivancic i sinovi
Hemofarm - the leading company for pharmaceutical products in Serbia - has acquired the assests of Ivancic i sinovi, including products, manufacturing plant in Stari Banovci, employees and intellectual property. The acquired company encompasses 114 employers.
Hemofarm officials have assured that more than thirty of Ivancic i sinovi's products will remain on the market under the same name, since they have already established the trust of many users.
The growth and development of local production, in line with the most demanding global pharmaceutical standards, have been pointed out as priority effects of the acquisition.
"By taking over the products, the plant and the assets of 'Ivancic i sinovi', Hemofarm is in a way competing against itself, breaking its own records. In a word, I see this acquisition as a benefit for the employees in both companies, and also for the Serbian economy, and especially for the consumers of products," emphasized Ronald Seeliger, the CEO of Hemofarm.
Етикети: Hemofarm Ivancic i Sinovi business aquisiton pharmaceuticals